About This Video
This video is
BioSante's drug for the treatment of female sexual dysfunction, LibiGel, is entering Phase III trials. The company's CEO explains what the drug would mean for the pharmaceutical sector.
This website uses Adobe® Flash™ Player 9
Download Flash Now
If you are using Internet Explorer, you will need to restart your browser
after installing Flash.
Adobe and Flash are registered trademarks of Adobe Systems incorporated.
All rights reserved.
